IL6 and COVID-19: Their findings underscored that severe COVID-19 cases had markedly elevated levels of NLR, Systemic Inflammation Index, and interleukin-6 (IL-6), among others, with NLR presenting an area under the curve of 0.76, indicating its efficacy in distinguishing between mild and severe cases.